These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4675488)

  • 21. [Study of the action of bromocriptine in hyperprolactinemic states. Results of a cooperative trial in 135 patients].
    Fossati P; Strauch G; Tourniaire J
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1687-91. PubMed ID: 986640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Effects of inhibition of prolactin secretion by 2-Br-alpha-ergocryptine at parturition and during lactation in dairy cows.
    Fell LR; Chandler NJ; Goding JR
    J Reprod Fertil; 1974 Feb; 36(2):480-1. PubMed ID: 4819349
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperprolactinaemic endocrinopathy in gynaecological practice (author's transl)].
    Alexander H; Herter U; Müller R; Brockmann J
    Zentralbl Gynakol; 1980; 102(6):346-52. PubMed ID: 7193390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases].
    Hartemann P; Leclere J; Groussin M; Valdenaire JC; Maureira JJ; Belleville F; Nabet P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Jun; 6(4):537-46. PubMed ID: 915214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hyperprolactinaemia and galactorrhoea in secondary amenorrhoea.
    Giwa-Osagie OF; Akinla OA; Coker OO; Sanyaolu AO
    Trop Geogr Med; 1983 Jun; 35(2):163-5. PubMed ID: 6684337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome.
    Corenblum B; Taylor PJ
    Fertil Steril; 1978 Oct; 30(4):388-92. PubMed ID: 581377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human prolactin. Evidence obtained by the bioassay of human plasma.
    Forsyth IA; Myres RP
    J Endocrinol; 1971 Sep; 51(1):157-68. PubMed ID: 5166463
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE; Reighlin S
    N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
    [No Abstract]   [Full Text] [Related]  

  • 29. Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.
    Mustaffa BE; Khalid BA; Satgunasingam N; Adeeb N; Tan PL; Chandran S
    Med J Malaysia; 1983 Sep; 38(3):237-43. PubMed ID: 6672568
    [No Abstract]   [Full Text] [Related]  

  • 30. Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin.
    Edwards CR; Forsyth IA; Besser GM
    Br Med J; 1971 Aug; 3(5772):462-4. PubMed ID: 5105903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raised serum PRL and androgen levels associated with hyrsutism, amenorrhoea and galactorrhoea.
    Malato M
    Acta Eur Fertil; 1978 Dec; 9(4):175-83. PubMed ID: 573041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of lactation and prolactin secretion in rats by ergot alkaloids.
    Shaar CJ; Clemens JA
    Endocrinology; 1972 Jan; 90(1):285-8. PubMed ID: 5009064
    [No Abstract]   [Full Text] [Related]  

  • 33. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa.
    Turkington RW; Gordon ES
    J Lab Clin Med; 1971 Nov; 78(5):824-5. PubMed ID: 5166936
    [No Abstract]   [Full Text] [Related]  

  • 35. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Schellekens LA; Roland R; Lequin RM
    Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
    Floss HG; Cassady JM; Robbers JE
    J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
    [No Abstract]   [Full Text] [Related]  

  • 37. The detection of lactogenic activity in human blood by bioassay.
    Forsyth IA
    J Endocrinol; 1970 Feb; 46(2):iv-v. PubMed ID: 5531075
    [No Abstract]   [Full Text] [Related]  

  • 38. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolactin release in cattle.
    Karg H; Schams D
    J Reprod Fertil; 1974 Aug; 39(2):463-72. PubMed ID: 4370292
    [No Abstract]   [Full Text] [Related]  

  • 40. Human prolactin.
    Daughaday WH; Jacobs LS
    Ergeb Physiol; 1972; 67():169-94. PubMed ID: 4196198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.